Abstract
A diverse collection of 261 Staphylococcus aureus strains from human, animal, food, and environmental sources were tested for the presence and type of SCCmec elements, antibiotic susceptibility to various antibiotics, and non-ß-lactam antibiotic resistance genes. About 18.39% (48/261) of strains were methicillin-resistant S. aureus (MRSA) including 29.75% (36/121) human strains of which 29 strains were hospital-acquired MRSA (HA-MRSA) and 7 strains were community-associated MRSA (CA-MRSA) and 19.67% (12/61) animal strains that all were CA-MRSA strains. The percentage of CA-MRSA strains from animals was significantly higher than that from human (p<0.01). Most of MRSA strains and a part of methicillin-susceptible S. aureus (MSSA) strains harbored unique combinations of non-ß-lactamase genes aac(6′)/aph(2″), aph(3′)-III, ant (4′,4″), ermA, ermC, mrsA, tetM, and tetK. Antibiotic resistance genes were detected more frequently in HA-MRSA strains than in CA-MRSA strains (p<0.01). MRSA strains and MSSA strains had 22 and 39 antibiotic profiles to 15 tested antibiotics, respectively. The resistant proportion was higher in HA-MRSA strains than in CA-MSSA strains for various antibiotics, as well as higher in MRSA strains than in MSSA strains. Animal MRSA reservoirs (particularly pigs and cows) might represent an important source of human CA-MRSA. CA-MRSA strains might acquire more different resistance genes gradually, depending on the selective pressure of antibiotics in different regions or environments. CA-MRSA is not yet endemic in China, but could be prevalent in future, contributing to its acquiring more resistance genes and huge animal sources. Infection with multidrug-resistant MSSA strains acquired from food, animal, and human sources might also become a significant problem for human medicine, which warrants further study.
Introduction
S
Animals such as domestic pets, livestock (particularly pigs), and wild birds have been identified as carriers of MRSA (mainly CA-MRSA) in regions that harbor common human MRSA strains (David and Daum, 2010). However, until recently, there have been few reports on the MRSA status of animal reservoirs in China (David and Daum, 2010; Wanfang Data, 2012).
Antibiotic resistance is a global problem. Under the selective pressure of excessive antibiotic use, local evolution of multidrug resistance (MDR) bacteria (resistance to three or more antibiotics) occurs through horizontal gene transfer, leading to the transmission of genes such as the ß-lactamase genes between bacterial species and strains (Hawkey and Jones, 2009). MRSA, particularly HA-MRSA, is usually associated with the expression of MDR genes including non-ß-lactam resistance genes encoding resistance to aminoglycosides, macrolides, and tetracyclines (David and Daum, 2010).
In this study, 261 strains from different sources such as human, animal, food, and environmental sources in China were characterized using phenotypic and molecular methods. All strains were tested for the presence and type of SCCmec elements, the presence of non-ß-lactam antibiotic resistance genes, and antibiotic susceptibility.
Materials and Methods
Bacterial strains
Among 261 total S. aureus strains, 121 were isolated from various patient tissue samples from one general hospital and two tertiary hospitals; 79 strains were obtained from food sources (n=75) and hair-cutting equipment (n=4); 61 strains were obtained from animals including 26 strains from raw cow milk from 21 dairy farms, 35 strains from healthy pigs (n=31 strains from 296 pig nasal swabs from 8 farms), dogs (n=2 strains from 40 dog rectal swabs from an animal hospital and a pet hospital), and chickens (n=2 strains from 94 chicken rectal swabs from one farm) between 2005 and 2011. All S. aureus strains in this study were identified by using the hemolysis test on blood agar, the coagulase test, and various biochemical tests with the ATB ID32 STAPH test system for identifying staphylococcus species (bioMerieux, Lyon, France). S. aureus ATCC25923 and ATCC43300 were used as reference strains for methicillin-susceptible S. aureus (MSSA) and MRSA, respectively.
Polymerase chain reaction amplification
Bacterial DNA was extracted using the TIANamp Bacteria DNA kit according to the manufacturer's instructions (Tiangen, Beijing, China).
The mecA gene and the SCCmec typing genes were tested according to a published multiplex polymerase chain reaction assay (Zhang et al., 2005). The presence of aac(6′)/aph(2″) (conferring resistance to gentamicin, kanamycin, and amikacin), aph(3″)-III (conferring resistance to kanamycin and neomycin), and ant (4′,4″) genes (conferring resistance to kanamycin and amikacin), ermA, ermC, and mrsA genes (conferring resistance to erythromycin), and tetM and tetK (conferring resistance to tetracyclines) was performed using the published primers (Doherty et al., 2000; Trzcinski et al., 2000; Udo and Dashti, 2000; Chen et al., 2008).
Antibiotic susceptibility testing
Susceptibility tests were performed by using the disk diffusion method (Clinical and Laboratory Standards Institute, 2010) to test for resistance to penicillin, oxacillin, cefoxitin, cefazolin, amikacin, gentamicin, ciprofloxacin, tetracycline, clindamycin, chloramphenicol, erythromycin, rifampicin, trimethoprim-sulfamethoxazole, vancomycin, and teicoplanin. All drugs for the disk diffusion assays were obtained from Oxoid Ltd. (Hampshire, England). Susceptibility results were interpreted according to the guidelines published by the Clinical and Laboratory Standards Institute (2010).
Results
SCCmec typing and antibiotic susceptibility of MRSA strains
Among 261 total strains, 18.39% (48/261) were MRSA based on resistance to cefoxitin and the expression of the mecA gene (CLSI, 2010).
About 29.75% (36/121) of strains from human tissue samples were found to be MRSA, including 23.97% (29/121) HA-MRSA and 5.79% (7/121) CA-MRSA; about 19.67% (12/61) of strains from animals were found to be CA-MRSA, including 25.81% (8/31) of pigs' source and 15.38% (4/26) of cows' source. No MRSA strains were isolated from food or environmental sources. There were 4 SCCmec types identified among the 48 MRSA strains: SCCmec type III, type I, type IVb, and type V, accounting for 55.83% (28/48), 2.08% (1/48)%, 8.33% (4/48), and 17.6% (11/48) of all MRSA strains, respectively; 8.33% (4/48) of MRSA strains were untypable. The strains of SCCmec type I (n=1) and type III (n=28) belonging to HA-MRSA were all from human sources, while the strains of SCCmec type IV (n=4) and type V (n=11) belonging to CA-MRSA were from human or animals: three SCCmec type IVb strains from pigs, one type IVd strain from a human, six type V strains from human, four strains type V strains from cows, and one type V strain from a pig. The four untypable SCCmec strains from pigs shared the same MLST type with the SCCmec type IV or V strains from pigs (all of which belong to ST9, data not shown). There were three additional MRSA strains (resistant to cefoxitin, one of which was isolated from a dog, and two of which were isolated from chicken) that were not included in the 48 MRSA strains mentioned above because they were not recovered in the study (data not shown).
Forty-eight MRSA strains harbored different combinations of aac(6′)/aph(2′′), aph(3′)-III, ant (4′,4′′), ermA, ermC, mrsA, tetM and tetK genes. These eight genes accounted for 75% (36/48), 43.75% (21/48), 52.08% (25/48), 58.33% (28/48), 45.83% (22/48), 27.08% (13/48), 70.83% (34/48), and 43.75% (21/48) of all MRSA strains, respectively. The various resistant genes proportion was higher in HA-MRSA strains than in CA-MSSA strains (Table 1).
Ox, oxacillin; Cx, cefoxitin; Cz, cefazolin; A, amikacin; G, gentamicin; Ci, ciprofloxacin; T, tetracycline; Cd, clindamycin; Ch, chloramphenicol; E, erythromycin; Ri, rifampicin; Sx, trimethoprim-sulfamethoxazole; NT, nontypeable; HA-MRSA, hospital-acquired methicillin-resistant Staphylococcus aureus; CA-MRSA, community-acquired S. aureus.
All MRSA strains were resistant to penicillin and cefoxitin; all strains were susceptible to vancomycin and teicoplanin.
+, Positive; +*, harbored the resistant gene(s) but were susceptible to its relative antibiotic(s) (in eight CA-MRSA strains and one HA-MRSA strain).
There was one profile in CA-MRSA was the smae with in HA-MRSA.
Final data total was 495, including 48 MRSA strains resistant to penicillin and cefoxitin (HA-MRSA strains : 362/29 ; CA-MRSA strains : 133/19).
All MRSA strains were resistant to penicillin and cefoxitin and were susceptible to vancomycin and teicoplanin. The resistance rates to oxacillin, cefazolin, amikacin, gentamicin, ciprofloxacin, tetracycline, clindamycin, chloromycetin, erythromycin, rifampicin, trimethoprim-sulfamethoxazole were 70.83% (34/48), 58.33% (28/48), 60.42% (29/48), 75% (36/48), 77.08% (37/48), 81.25% (39/48), 77.08% (37/48), 43.75% (21/48), 79.17% (38/48), 20.83% (10/48), and 87.50% (42/48), respectively. A total of 22 unique antibiotic profiles were identified in the MRSA isolates, and the resistant proportion was higher in HA-MRSA strains than in CA-MSSA strains for various antibiotics (Table 1).
Resistance genes and antibiotic susceptibility of MSSA strains
Among the 261 total strains, 213 were MSSA strains.
Among the 213 MSSA strains, the genes aac(6′)/aph(2′′), aph(3′′)-III, ant (4′,4′′), ermA, ermC, mrsA, tetM, and tetK accounted for 26.76% (57/213), 39.91% (85/213), 11.27% (24/213), 5.16% (11/213), 47.89% (102/213), 7.98% (17/213), 15.93% (33/213), and 24.88% (53/213), respectively.
Of the 213 MSSA strains, 15.02% (32/213) were susceptible to all tested antibiotics. Furthermore, all MSSA strains were susceptible to oxacillin, cefoxitin, cefazolin, vancomycin and teicoplanin. Antibiotic resistance rates for penicillin, amikacin, gentamicin, ciprofloxacin, tetracycline, clindamycin, chloromycetin, erythromycin, rifampicin, and trimethoprim-sulfamethoxazole were 71.36% (152/213), 2.35% (5/213), 10.33% (22/213), 10.80% (23/213), 27.70% (59/213), 12.68% (27/213), 5.16% (11/213), 45.07% (96/213), 1.88% (4/213), and 23.94% (51/213), respectively. Thirty-nine unique antibiotic resistance profiles were identified among the MSSA strains. Among the 213 MSSA strains, 29.58% (63/213) were resistant to one antibiotic, 26.76% (57/213) were resistant to two antibiotics, 11.74% (25/213) were resistant to three antibiotics, 5.16% (11/213) were resistant to four antibiotics, 5.63% (12/213) were resistant to five antibiotics, and 6.10% (13/213) were resistant to between six and nine antibiotics; the MDR MSSA (resistance to three or more antibiotics) strains was 28.64% (61/213) (see Supplementary Table S1; Supplementary Data are available online at
The non-ß-lactamase genes of aac(6′)/aph(2′′) (conferring resistance to gentamicin, kanamycin, and amikacin), and ant (4′,4′′) (conferring resistance to kanamycin and amikacin), ermA, ermC, and mrsA (conferring resistance to erythromycin), tetM and tetK (conferring resistance to tetracyclines) were detected in some strains that were susceptible to gentamicin, and/or amikacin and/or erythromycin, including nine MRSA stains (CA-MRSA strains mainly) and 103 MSSA strains (non-MDR MSSA strains mainly) (Table 1 and Supplementary Table S1).
Discussion
From 2001 to 2010, there have been reports regarding SCCmec typing of MRSA isolated from hospital settings in China. In all 1260 MRSA strains reported from Beijing (Wang et al., 2009; Zhao et al., 2011), Hunan (Pan, 2009), Shanghai (Zhang, 2009), Sichuan (Li et al., 2008), Zhejiang (Yu et al., 2006), Anhui (Ji et al., 2007), Tianjin and Wuhan (Kong et al., 2009), Shenzhen (Xiao et al., 2007), Ningxia (Zhang et al., 2011), Liaoning (Pan et al., 2011), and Guangdong (Ma et al., 2008), SCCmec type III accounted for 87.30% (1100/1260) cases followed by type II, type IV, type V, and type I, accounting for 6.59% (83/1260), 2.46% (31/1260), 0.79% (10/1260), and 0.40% (5/1260) of cases, respectively; 2.46% (31/1260) of MRSA strains were untypable. Our results and reports above indicate that HA-MRSA but not CA-MRSA remains the major pathogenic bacterium in the clinical setting; however, infections caused by CA-MRSA have been increasing in recent years. Until recently, there have been few reports regarding the epidemiology of CA-MRSA in China (David and Daum, 2010; Wanfang Data, 2012).
In Japan, Pakistan and India, and Korea, most of the MRSA strains that were isolated from hospitals were HA-MRSA (mainly type III or II), but infections by CA-MRSA have also been increasing in these countries in recent years (Ko et al., 2005; Ohkura et al., 2009; Park et al., 2009; Shabir et al., 2010; Yamada et al., 2011). HA-MRSA strains have been isolated largely from people who are exposed to the healthcare setting; inpatient hospital patients tend to be older and tend to have one or more comorbidities, which increases the chances of developing MRSA infections (Enright et al., 2002; Millar et al., 2007; Carvalho et al., 2010; David and Daum, 2010; Santos et al., 2010). The nosocomial environment also facilitates the development of HA-MRSA through the selective pressure of antibiotics.
CA-MRSA has emerged worldwide as a cause of infections among patients without the risk factors typically associated with hospital patients (David and Daum, 2010). In the current study, CA-MRSA strains were isolated from both human and animal sources including cows and pigs (as sources also including dogs and chickens). The percentage of CA-MRSA strains from animals was significantly higher than that from humans (19.67% versus 5.79%, p<0.01); also, the percentage of CA-MRSA strains from the porcine hosts and the cow hosts was significantly higher than that from humans, respectively (25.81% versus 5.79%, 15.38% versus 5.79%, p<0.01, respectively). Our results support the idea that animals function as reservoirs of CA-MRSA and source of human MRSA. There have been sporadic reports of CA-MRSA being isolated from animals in China: six CA-MRSA strains (five SCCmec type IV and one that could not be identified but belonged to ST9, the same ST as SCCmec type IV) out of 54 total S. aureus strains were isolated from diseased cows in five provinces (Wang et al., 2011); another 14 CA-MRSA strains (all of which belonged to SCCmec type IV) out of 83 total S. aureus strains were isolated from pigs in Shanxi province (Wang et al., 2010). Food animals, particularly pigs and dairy cows, have been found to be important sources of CA-MRSA infections in humans (Lee, 2003; Thorberg et al., 2006; Juhasz-Kaszanyitzky et al., 2007; Tiwari and Tiwari, 2007; van Loo et al., 2007; Khanna et al., 2008; van Rijen et al., 2008; Kock et al., 2009; Lozano et al., 2011). In our study, no MRSA strains were isolated from food or environmental sources; however, food and environmental sources may also serve as important CA-MRSA reservoirs because S. aureus has been shown to survive for long periods of time on inanimate objects (Simoes et al., 2011; Uhlemann et al., 2011). Some studies have reported about human carriers of CA-MRSA strains, but they could not identify the source of the pathogen (Chatterjee et al., 2009; David and Daum, 2010; Denis et al., 2009; Lamaro-Cardoso et al., 2009; Chen et al., 2011). Even so, animal reservoirs have increasingly been considered to represent an important source of human MRSA acquisition. Therefore, hospitalized patients may become colonized with both CA-MRSA and HA-MRSA as the community reservoir of CA-MRSA continues to increase (D'Agata et al., 2010).
The regional resistant genes combinations are more helpful for analyzing the resistance genotypes and phenotypes of S. aureus (Udo and Dashti, 2000). Most of MRSA strains and a part of MSSA stains harbored unique combinations of aac(6′)/aph(2′′), aph(3′)-III, and ant (4′,4′′), ermA, ermC, and mrsA, tetM, and tetK genes. Antibiotic resistance genes were detected more frequently in HA-MRSA strains than in CA-MRSA strains (p<0.01), and also more frequently in MRSA strains than in MSSA strains (p<0.01). Almost all of HA-MRSA strains carried three genes, aac(6′)/aph(2′′), ermA, tetM, conferring resistant to kanamycin and amikacin, erythromycin, tetracycline, the important antibiotics in clinic. CA-MRSA isolates have typically been susceptible to most non-ß-lactam antimicrobial drugs (David and Daum, 2010), while in this study, all CA-MRSA strains harbored different non-ß-lactam-resistant genes and are resistant to the majority of the relative antibiotics (Table 1). The results show that CA-MRSA strains might acquire different resistance genes gradually, depending on the selective pressure of antibiotics in different regions or environments.
Some strains harbored non-ß-lactamase genes but were susceptible to the relative antibiotics, and these genes were detected mainly in non-MDR MSSA strains and less in HA-MRSA strains. Other studies have also reported similar findings (Vanhoof et al., 1994; Udo and Dashti, 2000). The phenomenon in this study also confirmed that the resistance genes are acquired on the selective pressure exerted by antibiotics and antiseptics in the environment; these strains will express their resistance at the exposure of relative antibiotics at a later date (Udo and Dashti, 2000).
We observed that no MRSA strains were resistant to vancomycin and teicoplanin, and most MRSA strains were susceptible to chloramphenicol and rifampicin in this study. Certain MRSA strains have been reported to demonstrate resistance to vancomycin and teicoplanin in some countries (David and Daum, 2010). Almost all of the HA-MRSA strains were resistant to the non-ß-lactam antibiotics gentamicin, erythromycin, and tetracycline, while approximately half of the CA-MRSA strains were resistant to the same antibiotics. Our results show that HA-MRSA strains were significantly (p<0.01) more resistant to different antibiotics than CA-MSSA strains. The results also show that not only HA-MRSA but also CA-MRSA strains are developing resistance to more antibiotic agents. Information about MRSA and MSSA antibiotic profiles in this study is also important for the effective treatment of regional S. aureus infections. Statistical analysis revealed that the association between the antibiotics in MRSA strains and MSSA strains was highly significant (p<0.01). As the MDR MSSA strains were higher and these strains were obtained from animal, food, and human sources, the results suggest that drug-resistant bacteria or drug-resistance genes could be transferred from animals to food to humans, and that transfer in this manner could lead to the proliferation of increasingly drug-resistant strains (Aarestrup and Wegener, 1999). MDR MSSA strains obtained from food, animal, and human sources might also become an emerging problem for human medicine in terms of the spread of resistance, which warrants further investigation.
Conclusions
In conclusion, HA-MRSA remains a large problem in hospitals in China, whereas CA-MRSA is not yet endemic but appears to be increasing in prevalence in China. Animals such as pigs, cows, and household pets appear to serve as major reservoirs for CA-MRSA, which is often transmitted from animals to humans by direct contact. MRSA and MDR MSSA strains harbored many resistance genes in many unique combinations and thus displayed resistance to several antibiotics. Based on this study, our results support the value of increasing the surveillance of MRSA and implementing MRSA control measures in animals and humans in China.
Footnotes
Acknowledgments
This work was supported by grants from the National Science and Technology Support Plan (2012BAK17B10), the earmarked fund for Modern Agro-industry Technology Research System (CARS-41-K08), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Natural Sciences Foundation of Jiangsu Province (BK2010350), and the Natural Sciences Foundation of Yangzhou (YZ2010090). We would like to thank all individuals who kindly provided us with the strains used in this study.
Disclosure Statement
No competing financial interests exist.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
